Hong Kong stocks surged | Sun Shing Tai Pharmaceutical-B (02511.HK) soared over 38% in the afternoon, its core product HTD1801 with differentiated competitive advantages is expected to achieve commercialization.

According to the Securities Times app, Junsentai Pharmaceuticals-B (02511.HK) surged more than 38% in the afternoon, rising by 36.41% as of the time of publication to 2.66 Hong Kong dollars, with a trading volume of 21.0556 million Hong Kong dollars.